That ressource is reserved for health professionals

This space contains information on medical devices, the use of which is reserved for healthcare professionals. In application of the law of December 29, 2011 relating to the strengthening of health security, I certify that I am a health professional and therefore be authorized to access this information.

I am a healthcare professional


Close window if you are not a healthcare professional


Close menu



Ipilimumab-like - Labelled (Arg,Lys) 13C15N


Quantification of Ipilimumab

Specific labelling

Arginine: 13C6,15N4>99%

Lysine: 13C6,15N2, >99%


Labelled Ipilimumab-like is a recombinant, stable isotope labelled monoclonal IgG1-Kappa antibody containing proteotypic peptides derived from Ipilimumab’s originator sequence. Labelled Ipilimumab-like is designed for use as an internal standard for quantitative analysis of Ipilimumab in plasma samples. Ipilimumab targets the CTLA-4 protein and is used to treat Melanoma and Renal Cell Carcinoma.

This product is for research use only and is not intended for diagnostic or therapeutic use.